Greenleaf Trust Reduces Holdings in Procter & Gamble Company (The) $PG

Greenleaf Trust lowered its position in Procter & Gamble Company (The) (NYSE:PG) by 9.5% during the 2nd quarter, HoldingsChannel reports. The fund owned 62,507 shares of the company’s stock after selling 6,542 shares during the period. Greenleaf Trust’s holdings in Procter & Gamble were worth $9,166,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in PG. Carson Advisory Inc. raised its position in Procter & Gamble by 0.5% in the 4th quarter. Carson Advisory Inc. now owns 12,124 shares of the company’s stock worth $1,738,000 after purchasing an additional 65 shares during the period. Cary Street Partners Investment Advisory LLC boosted its position in shares of Procter & Gamble by 1.8% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company’s stock valued at $549,000 after buying an additional 67 shares during the period. Cowa LLC grew its stake in shares of Procter & Gamble by 2.4% during the fourth quarter. Cowa LLC now owns 2,985 shares of the company’s stock valued at $428,000 after buying an additional 70 shares during the last quarter. KLCM Advisors Inc. lifted its stake in shares of Procter & Gamble by 0.9% during the 1st quarter. KLCM Advisors Inc. now owns 7,890 shares of the company’s stock worth $1,140,000 after acquiring an additional 70 shares during the last quarter. Finally, Park Square Financial Group LLC lifted its stake in shares of Procter & Gamble by 65.1% during the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock worth $26,000 after acquiring an additional 71 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

Shares of PG stock opened at $145.51 on Tuesday. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. The stock has a fifty day simple moving average of $147.06 and a two-hundred day simple moving average of $148.12. The stock has a market capitalization of $338.23 billion, a price-to-earnings ratio of 21.98, a P/E/G ratio of 4.43 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating the consensus estimate of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.The firm had revenue of $21.20 billion for the quarter, compared to analyst estimates of $21.38 billion. During the same quarter last year, the firm posted $1.48 earnings per share. The business’s revenue for the quarter was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, analysts predict that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, August 17th. Stockholders of record on Friday, July 24th were issued a $1.0885 dividend. The ex-dividend date was Friday, July 24th. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. Procter & Gamble’s payout ratio is currently 65.71%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on PG shares. Argus downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Friday, August 7th. Bank of America lowered their target price on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research note on Friday, July 10th. Jefferies Financial Group upped their price target on shares of Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a report on Friday, June 26th. Citigroup reduced their price target on shares of Procter & Gamble from $181.00 to $170.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. Finally, HSBC reissued a “hold” rating and issued a $149.00 price objective (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. Thirteen equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $161.19.

Insider Transactions at Procter & Gamble

In other news, insider Susan Street Whaley sold 2,238 shares of the stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $143.79, for a total transaction of $321,802.02. Following the transaction, the insider directly owned 26,989 shares in the company, valued at approximately $3,880,748.31. This trade represents a 7.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Matthew W. Janzaruk sold 359 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $145.24, for a total transaction of $52,141.16. Following the transaction, the chief accounting officer directly owned 1,271 shares in the company, valued at approximately $184,600.04. The trade was a 22.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 6,627 shares of company stock valued at $953,417. Company insiders own 0.20% of the company’s stock.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Several recent articles identify PG as a leading dividend stock for 2027 and beyond, emphasizing its dependable income, long record of dividend growth and resilience across economic cycles. This supports demand from income-oriented and defensive investors. The Best Dividend Stock for 2027 and Beyond: Procter & Gamble
• Positive Sentiment: PG is being presented as an attractive alternative to simply owning the Consumer Staples Select Sector SPDR Fund (XLP), reflecting investor interest in selecting high-quality individual dividend payers with established household brands. These 3 Dividend Stocks Make a Strong Case for Skipping XLP
• Neutral Sentiment: The bullish investment case also depends on productivity improvements, new product innovation and robust cash returns. Those factors could help offset modest underlying growth, although PG’s valuation remains relatively rich. Is P&G Stock Worth Buying as Growth Slows and Valuation Stays Rich?
• Negative Sentiment: Analysts highlight an estimated 8% fiscal 2027 core EPS headwind from higher input costs, financing expenses, lower non-operating income and unfavorable currency movements. These pressures could limit earnings growth and weigh on the stock’s premium valuation. P&G Fiscal 2027 Outlook Brings an 8% Core EPS Headwind Into Focus
• Negative Sentiment: Erste Group Bank issued a bearish forecast for PG’s fiscal 2027 earnings, reinforcing concerns that the company’s near-term fundamentals may not justify its valuation. Erste Group Bank Has Bearish Forecast for PG FY2027 Earnings

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.